Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
21.11
+1.89 (9.83%)
Aug 13, 2025, 4:00 PM - Market closed
Neurogene Market Cap
Neurogene has a market cap or net worth of $301.28 million as of August 14, 2025. Its market cap has decreased by -45.65% in one year.
Market Cap
301.28M
Enterprise Value
37.73M
1-Year Change
-45.65%
Ranking
Category
Stock Price
$21.11
Market Cap Chart
Since March 7, 2014, Neurogene's market cap has increased from $114.10M to $301.28M, an increase of 164.05%. That is a compound annual growth rate of 8.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 290.40M | -14.49% |
| Dec 31, 2024 | 339.60M | 646.37% |
| Dec 29, 2023 | 45.50M | 109.68% |
| Dec 30, 2022 | 21.70M | -89.39% |
| Dec 31, 2021 | 204.50M | -65.38% |
| Dec 31, 2020 | 590.70M | 25.07% |
| Dec 31, 2019 | 472.30M | 829.72% |
| Dec 31, 2018 | 50.80M | -81.59% |
| Dec 29, 2017 | 275.90M | -28.65% |
| Dec 30, 2016 | 386.70M | 80.03% |
| Dec 31, 2015 | 214.80M | 167.83% |
| Dec 31, 2014 | 80.20M | -29.71% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |